These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32709663)

  • 1. Primary plasma cell leukaemia in a 39-year-old man.
    Kasinathan G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32709663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Plasma Cell Leukemia: Identity Card 2016.
    Musto P; Simeon V; Todoerti K; Neri A
    Curr Treat Options Oncol; 2016 Apr; 17(4):19. PubMed ID: 26995215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
    Mina R; Joseph NS; Kaufman JL; Gupta VA; Heffner LT; Hofmeister CC; Boise LH; Dhodapkar MV; Gleason C; Nooka AK; Lonial S
    Cancer; 2019 Feb; 125(3):416-423. PubMed ID: 30332496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G; Richardson PG; Anderson KC
    J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation.
    Tang ASO; Ahmad Asnawi AW; Koh AZY; Chong SL; Liew PK; Selvaratnam V; Md Fauzi A; Lau NS; Tan SM
    Am J Case Rep; 2023 Mar; 24():e938868. PubMed ID: 36882990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
    Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
    J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell leukemia mimicking hairy cell leukemia.
    Hanbali A; Alrajeh A; Rasheed W
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):91-2. PubMed ID: 26013472
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cells with hairy projections and Auer rod-like inclusions in a patient with multiple myeloma.
    Sharma P; Sachdeva MUS; Ahluwalia J; Malhotra P
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28775092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in the Diagnosis and Therapy of Primary Plasma Cell Leukemia -Review].
    Wang H; Li JY; Sun C; Zhou X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1837-1841. PubMed ID: 29262927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidation therapy with autologous blood stem cell transplantation in a patient with primary plasma cell leukaemia.
    Mak YK; Chan CH; Chen YT; Lau SM; So CC; Wong KF
    Clin Lab Haematol; 2003 Feb; 25(1):55-8. PubMed ID: 12542443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stringent complete remission of primary plasma cell leukemia with reduced-dose bortezomib, lenalidomide and dexamethasone: a case report and review of the literature.
    Ueda S; Kubo M; Matsuura N; Matsunaga H; Kataoka S; Maeda T; Inui Y; Kawata S; Kanakura Y
    Intern Med; 2013; 52(11):1235-8. PubMed ID: 23728562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical perspective on plasma cell leukemia; current status and future directions.
    Tuazon SA; Holmberg LA; Nadeem O; Richardson PG
    Blood Cancer J; 2021 Feb; 11(2):23. PubMed ID: 33563906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
    Durie BGM; Hoering A; Abidi MH; Rajkumar SV; Epstein J; Kahanic SP; Thakuri M; Reu F; Reynolds CM; Sexton R; Orlowski RZ; Barlogie B; Dispenzieri A
    Lancet; 2017 Feb; 389(10068):519-527. PubMed ID: 28017406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early relapse after complete remission of primary plasma cell leukaemia manifesting clonal evolution: A case report.
    Nyunt WWT; Abdul Jalil D; Zakariah NA; Abdul Karim N; Mohd Idris MR; Nasuruddin DN; Salwati SHUIB; Alauddin H; Tumian NR; Leong CF; Abdul Wahid SFS
    Malays J Pathol; 2020 Apr; 42(1):143-150. PubMed ID: 32342945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary plasma cell leukemia presenting as a thoracic mass.
    Igala M; Bopaka RG; Khtabi W; Benchekroun S; Quessar A
    Pan Afr Med J; 2014; 19():39. PubMed ID: 25667701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia.
    Galakhoff N; Leven C; Eveillard JR; Tempescul A; Kerspern H; Aubron C; Buors C; Lippert É; Carré JL; Padelli M
    Biochem Med (Zagreb); 2020 Feb; 30(1):010801. PubMed ID: 31839726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoplasmacytoid cytology in plasma cell leukemia.
    Khoder A; Al Obaidi M; Wiles N; Nadal-Melsio E; Bain BJ
    Am J Hematol; 2018 Mar; 93(3):460-461. PubMed ID: 29027254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment for plasma cell leukemia].
    Miwa A
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():628-41. PubMed ID: 23134023
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature.
    Sekiguchi Y; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(8):9609-19. PubMed ID: 26464727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.